Impact of Lymph Node Management on Resectable Non-Small Cell Lung Cancer Patients

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2017.02.90
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

P017 Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Significance of Skipping Mediastinal Lymph Node Metastasis in N2 Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

P3.16-24 Prognostic Value of Positive Lymph Node Ratio in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.16-29 Prediction of Lymph Node Metastases in Clinical T1aN0M0 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Impact of CD8 and Programmed Death-Ligand 1 Expression in Patients With Resectable Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Preoperative Platelet Count in Predicting Lymph Node Metastasis and Prognosis in Patients With Non-Small Cell Lung Cancer

Neoplasma
Cancer Research
2012English

Choice of Postoperative Radiation for Stage IIIA Pathologic N2 Non-Small Cell Lung Cancer: Impact of Metastatic Lymph Node Number

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Surgery in Microscopically Pathological N2 Non-Small Cell Lung Cancer: The Size of Lymph Node Matters

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Prognostic Value of Number of Negative Lymph Node in Patients With Stage II and IIIa Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy